Oral semaglutide 25 mg in adults with overweight or obesity
study053
10.1056/NEJMoa2403347
New England Journal of Medicine
randomized clinical trial
Oral semaglutide 25 mg was studied for weight management in adults with overweight or obesity.
Oral semaglutide 25 mg led to greater mean weight reduction than placebo.
semaglutide
fat-loss|metabolism
metabolic-stack
semaglutide-vs-tirzepatide
published